Cargando…
Diagnostic utility of triple antibody (AMACR, HMWCK and P63) stain in prostate neoplasm
AIMS AND OBJECTIVE: In recent period, basal cell markers high molecular weight cytokeratin (HMWCK), P63 and prostate biomarker AMACR have been used as adjuvant to morphology in diagnostically challenging cases with a very high sensitivity and specificity. MATERIALS AND METHODS: In this prospective s...
Autores principales: | Rathod, Santosh G., Jaiswal, Deelip G., Bindu, Rajan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753827/ https://www.ncbi.nlm.nih.gov/pubmed/31548949 http://dx.doi.org/10.4103/jfmpc.jfmpc_432_19 |
Ejemplares similares
-
Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer
por: Kumaresan, K, et al.
Publicado: (2010) -
Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium
por: Nili, Fatemeh, et al.
Publicado: (2023) -
The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013) -
Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
por: Alinezhad, Saeid, et al.
Publicado: (2016) -
Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma
por: Srinivasan, Malini, et al.
Publicado: (2011)